Stay updated with breaking news from Light Cystoscopy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release - Oslo, Norway, March 28, 2024: Photocure ASA, The Bladder Cancer Company, announces the publication of the study Racial Difference in Detection Rate of Bladder Cancer Using Blue Light...
/PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 88.9 million in the second quarter of 2021 (Q2 2020: NOK 53.5), and...
®/Cysview ® revenues of NOK 81.6 million in the first quarter of 2021 (Q1 2020: NOK 54.4 million), and EBITDA of NOK 18.1 million (NOK -4.8 million), following the continued successful launch in markets previously operated by Ipsen Pharma SAS. The third Covid-19 wave impacted operations in the quarter, but a strong March performance indicates the environment is improving. "For the first quarter of 2021, Photocure delivered a 50% YoY increase in Hexvix/Cysview sales, unit growth in our U.S. segment, and positive EBITDA driven by the added revenue in Europe, cost containment, and the payment...